NR3C2 and Hyperkalemia: While loop diuretics, thiazide diuretics, and potassium binders may reduce hyperkalaemia, the kaliuretic effects of SGLT2 inhibitors have been recently shown reduce the incidence of hyperkalaemia associated with RAAS blockade or MR antagonists usage, and thus may also help to facilitate prescription of goal directed medical therapy [104–106].